Can Sitagliptin reduce cardiovascular risks in high-risk diabetic patients, and what evidence supports its protective effects on heart health?
Share
IVF Questions & Answers
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Can Sitagliptin reduce cardiovascular risks in high-risk diabetic patients, and what evidence supports its protective effects on heart health?
Sitagliptin hasn’t conclusively been shown to reduce cardiovascular risks in high-risk diabetic patients. Studies like TECOS showed it didn’t increase risk but also didn’t provide significant protective benefits.